FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Börje Ljungberg

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Physiology

Gene Expression Regulation, Neoplastic

Anatomy

Co-author Network

Publications

TOP 3
Börje Ljungberg
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
Xingru Li; Börje Ljungberg; Raviprakash T Sitaram; Sihan Wang; Charlotta Andersson; Aihong Li
Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma.
Christel Häggström; Göran Hallmans; Håkan Jonsson; Börje Ljungberg; Jonas Manjer; Gabriele Nagel; Kilian Rapp; Randi Selmer; Martin Almqvist; Tone Bjørge; Hans Concin; Anders Engeland; Tanja Stocks; Steinar Tretli; Hanno Ulmer; Pär Stattin
Metabolic factors associated with risk of renal cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Börje Ljungberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Börje Ljungberg
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
Current urology reports 2013;14(1):19-25.
2013: Xingru Li; Börje Ljungberg; Raviprakash T Sitaram; Sihan Wang; Charlotta Andersson; Aihong Li
Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma.
PloS one 2013;8(3):e58396.
2013: Christel Häggström; Göran Hallmans; Håkan Jonsson; Börje Ljungberg; Jonas Manjer; Gabriele Nagel; Kilian Rapp; Randi Selmer; Martin Almqvist; Tone Bjørge; Hans Concin; Anders Engeland; Tanja Stocks; Steinar Tretli; Hanno Ulmer; Pär Stattin
Metabolic factors associated with risk of renal cell carcinoma.
PloS one 2013;8(2):e57475.
2013: Ulrika Svenson; E Grönlund; Börje Ljungberg; Raviprakash T Sitaram; Ingegerd Söderström; Göran Roos
Telomere length in relation to immunological parameters in patients with renal cell carcinoma.
PloS one 2013;8(2):e55543.
2013: Karin Papworth; Anders Bergh; Kjell Grankvist; Börje Ljungberg; Johanna Sandlund; Torgny Rasmuson
Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 2013;52(1):159-65.
2012: Marcus Thomasson; Börje Ljungberg; Håkan Hedman; Roger Henriksson
Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.
BMC research notes 2012;5():216.
2011: Börje Ljungberg; Steffen Weikert; Han Yong Choi; Jung Eun Lee; Steven C Campbell; Han Yong Cho; Didier Jacqmin; Lambertus A Kiemeney
The epidemiology of renal cell carcinoma.
European urology 2011;60(4):615-21.
2011: Jonas Sjölund; Anna-Karin Boström; Erik Fredlund; Martin Johansson; David Lindgren; Börje Ljungberg; Sugata Manna; Aristidis Moustakas; Håkan Axelson
The notch and TGF-β signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma.
PloS one 2011;6(8):e23057.
2010: R T Sitaram; S Degerman; Börje Ljungberg; E Andersson; Y Oji; H Sugiyama; Göran Roos; A Li
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.
British journal of cancer 2010;103(8):1255-62.
2010: Börje Ljungberg; Nigel C Cowan; Damian C Hanbury; Milan Hora; Markus A Kuczyk; Axel S Merseburger; Jean-Jacques Patard; Peter F A Mulders; Ioanel C Sinescu
EAU guidelines on renal cell carcinoma: the 2010 update.
European urology 2010;58(3):398-406.
2010: Börje Ljungberg
Kidney cancer: A new nomogram predicting survival in renal cell carcinoma.
Nature reviews. Urology 2010;7(8):423-4.
2010: Karin Papworth; Johanna Sandlund; Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson
Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
Anticancer research 2010;30(7):2953-7.
2009: Raviprakash T Sitaram; Claire J Cairney; Pawel Grabowski; Nicol Keith; Bengt Hallberg; Börje Ljungberg; Göran Roos
The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
International journal of cancer. Journal international du cancer 2009;125(4):783-90.
2009: Börje Ljungberg
Contemporary status of open nephron-sparing surgery in renal cell carcinoma.
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 2009;81(2):61-4.
2009: Börje Ljungberg
Words of wisdom. Re: Radical nephrectomy with and without lymph-node dissection: final results of european organization for research and treatment of cancer (EORTC) randomized phase 3 trial 30881.
European urology 2009;55(6):1486-7.
2009: Ulrika Svenson; Börje Ljungberg; Göran Roos
Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma.
Cancer research 2009;69(7):2896-901.
2009: Hongjuan Zhao; Robert Tibshirani; John P T Higgins; Börje Ljungberg; James D Brooks
Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas.
PloS one 2009;4(6):e6039.
2009: Karin Papworth; Anders Bergh; Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson
Expression of erythropoietin and its receptor in human renal cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(2):86-92.
2009: Torvald Granfors; Radisa Tomic; Börje Ljungberg
Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Scandinavian journal of urology and nephrology 2009;43(4):293-9.
2009: Johanna Sandlund; Börje Ljungberg; Pernilla Wikström; Kjell Grankvist; Gudrun Lindh; Torgny Rasmuson
Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 2009;48(6):909-14.
2009: P L Lindberg; Britt M Andersson; Anders Bergh; Börje Ljungberg; Olof A Lindahl
An image analysis method for prostate tissue classification: preliminary validation with resonance sensor data.
Journal of medical engineering & technology 2009;33(1):18-24.
2008: Ville Jalkanen; Britt M Andersson; Anders Bergh; Börje Ljungberg; Olof A Lindahl
Explanatory models for a tactile resonance sensor system-elastic and density-related variations of prostate tissue in vitro.
Physiological measurement 2008;29(7):729-45.
2008: Anders Lidgren; Anders Bergh; Kjell Grankvist; Torgny Rasmuson; Börje Ljungberg
Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
BJU international 2008;101(4):480-4.
2008: Jonas Sjölund; Martin Johansson; Sugata Manna; Carl Norin; Alexander Pietras; Siv Beckman; Elise Nilsson; Börje Ljungberg; Håkan Axelson
Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.
The Journal of clinical investigation 2008;118(1):217-28.
2007: Ville Jalkanen; Britt M Andersson; Anders Bergh; Börje Ljungberg; Olof A Lindahl
Spatial variations in prostate tissue histology as measured by a tactile resonance sensor.
Physiological measurement 2007;28(10):1267-81.
2007: Börje Ljungberg
Prognostic markers in renal cell carcinoma.
Current opinion in urology 2007;17(5):303-8.
2007: Johanna Sandlund; Egbert Oosterwijk; Kjell Grankvist; Jeannette C Oosterwijk-Wakka; Börje Ljungberg; Torgny Rasmuson
Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.
BJU international 2007;100(3):556-60.
2007: Börje Ljungberg; Damian C Hanbury; Markus A Kuczyk; Axel S Merseburger; Peter F A Mulders; Jean-Jacques Patard; Ioanel C Sinescu
Renal cell carcinoma guideline.
European urology 2007;51(6):1502-10.
2007: Johanna Sandlund; Ylva Hedberg; Anders Bergh; Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson
Evaluation of CD31 (PECAM-1) expression using tissue microarray in patients with renal cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(3):158-64.
2007: Farhood Iranparvar Alamdari; Torgny Rasmuson; Kjell Grankvist; Börje Ljungberg
Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma.
Scandinavian journal of urology and nephrology 2007;41(1):5-9.
2006: Ville Jalkanen; Britt M Andersson; Anders Bergh; Börje Ljungberg; Olof A Lindahl
Resonance sensor measurements of stiffness variations in prostate tissue in vitro--a weighted tissue proportion model.
Physiological measurement 2006;27(12):1373-86.
2006: Peter Lindberg; Britt Andersson; Anders Bergh; Börje Ljungberg; Olof A Lindahl
Prostate cancer detection with an improved resonance sensor system: parameter evaluation in a silicone model and on human prostate tissue in vitro.
Medical & biological engineering & computing 2006;44(12):1053-9.
2006: Anders Lidgren; Ylva Hedberg; Kjell Grankvist; Torgny Rasmuson; Anders Bergh; Börje Ljungberg
Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
European urology 2006;50(6):1272-7.
2006: Kristina Hotakainen; Susanna Lintula; Börje Ljungberg; Patrik Finne; Annukka Paju; Ulf-Hakan Stenman; Jakob Stenman
Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.
The Journal of molecular diagnostics : JMD 2006;8(5):598-603.
2006: Börje Ljungberg; Jan Jacobsen; Stina Häggström Rudolfsson; Gudrun Lindh; Kjell Grankvist; Torgny Rasmuson
Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
BJU international 2006;98(3):661-7.
2006: Ville Jalkanen; Britt M Andersson; Anders Bergh; Börje Ljungberg; Olof A Lindahl
Prostate tissue stiffness as measured with a resonance sensor system: a study on silicone and human prostate tissue in vitro.
Medical & biological engineering & computing 2006;44(7):593-603.
2006: Jan Jacobsen; Kjell Grankvist; Torgny Rasmuson; Börje Ljungberg
Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma.
BJU international 2006;97(5):1102-8.
2006: Johanna Sandlund; Ylva Hedberg; Anders Bergh; Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson
Endoglin (CD105) expression in human renal cell carcinoma.
BJU international 2006;97(4):706-10.
2006: Hongjuan Zhao; Börje Ljungberg; Kjell Grankvist; Torgny Rasmuson; Robert Tibshirani; James D Brooks
Gene expression profiling predicts survival in conventional renal cell carcinoma.
PLoS medicine 2006;3(1):e13.
2005: Karin Papworth; Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson
Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(4):201-6.
2005: Anders Lidgren; Ylva Hedberg; Kjell Grankvist; Torgny Rasmuson; Janos Vasko; Börje Ljungberg
The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1129-35.
2005: Farhood Iranparvar Alamdari; Börje Ljungberg
Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system.
Scandinavian journal of urology and nephrology 2005;39(4):277-82.
2004: Börje Ljungberg
Prognostic factors in renal cell carcinoma.
Der Urologe. Ausg. A 2004;43 Suppl 3():S119-20.
2004: Ylva Hedberg; Börje Ljungberg; Göran Roos; Göran Landberg
Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.
International journal of cancer. Journal international du cancer 2004;109(2):189-93.
2004: Jan Jacobsen; Kjell Grankvist; Torgny Rasmuson; Anders Bergh; G Landberg; Börje Ljungberg
Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
BJU international 2004;93(3):297-302.
2004: Torgny Rasmuson; Kjell Grankvist; Jan Jacobsen; Tommy Olsson; Börje Ljungberg
Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 2004;43(8):744-8.
2004: Marcus Thomasson; Håkan Hedman; Teemu T Junttila; Klaus Elenius; Börje Ljungberg; Roger Henriksson
ErbB4 is downregulated in renal cell carcinoma--a quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family.
Acta oncologica (Stockholm, Sweden) 2004;43(5):453-9.
2003: Marcus Thomasson; Håkan Hedman; D Guo; Börje Ljungberg; Roger Henriksson
LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis.
British journal of cancer 2003;89(7):1285-9.
2003: Börje Ljungberg; Jan Jacobsen; Stina Häggström-Rudolfssson; Torgny Rasmuson; Gudrun Lindh; Kjell Grankvist
Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.
Urological research 2003;31(5):335-40.
2003: Ylva Hedberg; Börje Ljungberg; Göran Roos; Göran Landberg
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.
British journal of cancer 2003;88(9):1417-23.
2003: Kristina Hotakainen; Börje Ljungberg; Caj Haglund; Stig Nordling; Annukka Paju; Ulf-Hakan Stenman
Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.
International journal of cancer. Journal international du cancer 2003;104(5):631-5.
2002: Ylva Hedberg; Estela Davoodi; Börje Ljungberg; Göran Roos; Göran Landberg
Cyclin E and p27 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D.
International journal of cancer. Journal international du cancer 2002;102(6):601-7.
2002: Jan Jacobsen; Kjell Grankvist; Torgny Rasmuson; Börje Ljungberg
Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2002;11(3):245-52.
2002: Kristina Hotakainen; Börje Ljungberg; Annukka Paju; Torgny Rasmuson; Henrik Alfthan; Ulf-Hakan Stenman
The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma.
British journal of cancer 2002;86(2):185-9.
2002: Ylva Hedberg; Göran Roos; Börje Ljungberg; Göran Landberg
Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters.
Acta oncologica (Stockholm, Sweden) 2002;41(2):175-81.
2001: Torgny Rasmuson; Kjell Grankvist; Jan Jacobsen; Börje Ljungberg
Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2001;37(17):2199-203.
2001: Börje Ljungberg; L Abramsson; G Roos
Diagnosis of renal cell carcinoma by bone marrow aspiration biopsy.
Scandinavian journal of urology and nephrology 2001;35(4):334-6.
2001: Annukka Paju; Jan Jacobsen; Torgny Rasmuson; Ulf-Hakan Stenman; Börje Ljungberg
Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
The Journal of urology 2001;165(3):959-62.
2001: Börje Ljungberg; B Bozoky; G Kovacs; Pär Stattin; E Farrelly; Karin Nylander; Göran Landberg
p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
Scandinavian journal of urology and nephrology 2001;35(1):15-20.
2001: Torgny Rasmuson; Börje Ljungberg; Kjell Grankvist; Jan Jacobsen; Tommy Olsson
Increased serum cortisol levels are associated with high tumour grade in patients with renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 2001;40(1):83-7.
2000: Börje Ljungberg; Göran Landberg; Farhood Iranparvar Alamdari
Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy.
Scandinavian journal of urology and nephrology 2000;34(4):246-51.
2000: Jan Jacobsen; Torgny Rasmuson; Kjell Grankvist; Börje Ljungberg
Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.
The Journal of urology 2000;163(1):343-7.
1999: Börje Ljungberg; Farhood Iranparvar Alamdari; Roger Stenling; G Roos
Prognostic significance of the Heidelberg classification of renal cell carcinoma.
European urology 1999;36(6):565-9.
1999: A Lukkonen; Susanna Lintula; Kristina von Boguslawski; O Carpén; Börje Ljungberg; G Landberg; Ulf-Hakan Stenman
Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients.
International journal of cancer. Journal international du cancer 1999;83(4):486-90.
1999: Börje Ljungberg; Farhood Iranparvar Alamdari; Torgny Rasmuson; G Roos
Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy.
BJU international 1999;84(4):405-11.
1999: Ylva Hedberg; E Davoodi; Göran Roos; Börje Ljungberg; Göran Landberg
Cyclin-D1 expression in human renal-cell carcinoma.
International journal of cancer. Journal international du cancer 1999;84(3):268-72.
1999: Börje Ljungberg; B Osterdahl; C Mehle
Clinical significance of nm23 expression in renal cell carcinoma.
Urological research 1999;27(2):103-7.
1999: Börje Ljungberg; Radisa Tomic; SO Hietala; T Davidsson
Ureteric obstruction due to kinking of the reservoir inlet in a continent urinary reservoir.
Scandinavian journal of urology and nephrology 1999;33(2):126-8.
1999: Torgny Rasmuson; Kjell Grankvist; Göran Roos; Börje Ljungberg
Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
Acta oncologica (Stockholm, Sweden) 1999;38(5):623-8.
1998: C Mehle; A Lindblom; Börje Ljungberg; Roger Stenling; Göran Roos
Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma.
International journal of oncology 1998;13(2):289-95.
1998: Conny Arnerlöv; M Lundblad; S O Hietala; Börje Ljungberg
Renal mobility in a clinical patient material submitted for urography.
Scandinavian journal of urology and nephrology 1998;32(3):181-5.
1998: Börje Ljungberg; Farhood Iranparvar Alamdari; G Holmberg; Torvald Granfors; Milos Duchek
Radical nephrectomy is still preferable in the treatment of localized renal cell carcinoma. A long-term follow-up study.
European urology 1998;33(1):79-85.
1997: Börje Ljungberg; Kjell Grankvist; Torgny Rasmuson
Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1794-8.
1997: Radisa Tomic; T Angström; Börje Ljungberg
Cellular changes in prostatic carcinoma after treatment with orchidectomy, estramustine phosphate and medroxyprogesterone acetate.
Scandinavian journal of urology and nephrology 1997;31(3):255-8.
1997: Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson
Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma.
International journal of cancer. Journal international du cancer 1997;74(2):233-6.
1997: Torgny Rasmuson; Kjell Grankvist; Börje Ljungberg
Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma.
British journal of cancer 1997;75(11):1674-7.
1996: P Larsson; Göran Roos; Roger Stenling; Börje Ljungberg
Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.
Scandinavian journal of urology and nephrology 1996;30(6):445-50.
1996: Torvald Granfors; M Duchek; Radisa Tomic; Göran Roos; Börje Ljungberg
Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy.
Scandinavian journal of urology and nephrology 1996;30(4):281-5.
1996: C Mehle; M A Piatyszek; Börje Ljungberg; J W Shay; Göran Roos
Telomerase activity in human renal cell carcinoma.
Oncogene 1996;13(1):161-6.
1996: Börje Ljungberg; C Mehle; Roger Stenling; Göran Roos
Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
British journal of cancer 1996;74(1):123-7.
1996: P Larsson; Göran Roos; Roger Stenling; George D Wilson; Börje Ljungberg
Cell proliferation in renal cell carcinoma--a comparative study of cell kinetic methods.
Urological research 1996;24(5):291-5.
1996: Torgny Rasmuson; Kjell Grankvist; Börje Ljungberg
Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 1996;35(4):479-82.
1995: E Carlsson-Farrelly; L Boquist; Börje Ljungberg
Accuracy of clinical staging in non-seminomatous testicular cancer--a single centre experience of retroperitoneal lymph node dissection.
Scandinavian journal of urology and nephrology 1995;29(4):501-6.
1995: Börje Ljungberg; R Stenling; B Osterdahl; E Farrelly; T Aberg; G Roos
Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival.
The Journal of urology 1995;154(5):1681-4.
1995: Börje Ljungberg; Kjell Grankvist; Torgny Rasmuson
Serum acute phase reactants and prognosis in renal cell carcinoma.
Cancer 1995;76(8):1435-9.
1994: Börje Ljungberg; P Larsson; G Roos; R Stenling; G Wilson
Cell kinetics of renal cell carcinoma studied with in vivo iododeoxyuridine incorporation and flow cytometry.
The Journal of urology 1994;151(6):1509-13.
1994: P Larsson; G Roos; R Stenling; Börje Ljungberg
Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistry.
Scandinavian journal of urology and nephrology 1994;28(2):135-40.
1994: Torgny Rasmuson; K Grankvist; Börje Ljungberg
Re: False-positive prostate specific antigen values in the sera of women with renal cell carcinoma.
The Journal of urology 1994;151(3):704-5.
1994: Börje Ljungberg; Mats Gåfvels; Jan-Erik Damber
Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy.
Urological research 1994;22(5):305-8.
1993: Torgny Rasmuson; Kjell Grankvist; Börje Ljungberg
Serum gamma-enolase and prognosis of patients with renal cell carcinoma.
Cancer 1993;72(4):1324-8.
1993: C Mehle; Börje Ljungberg; Roger Stenling; Göran Roos
DNA fingerprinting of renal cell carcinoma with special reference to tumor heterogeneity.
Genes, chromosomes & cancer 1993;6(2):86-91.
1992: Börje Ljungberg; Torgny Rasmuson; Kjell Grankvist
Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker.
European urology 1992;21(2):160-3.
1992: G Holmberg; SO Hietala; Börje Ljungberg
Multiple renal masses in patients with renal cell carcinoma: diagnostic pitfalls and surgical implications.
Scandinavian journal of urology and nephrology 1992;26(4):367-71.
1991: Torgny Rasmuson; G R Björk; S O Hietala; R Stenling; Börje Ljungberg
Excretion of pseudouridine as an independent prognostic factor in renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 1991;30(1):11-5.
1991: Börje Ljungberg; I Nordenson; G Roos
Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma.
European urology 1991;19(1):59-64.
1991: N O Bengtsson; P Lenner; M Sjödin; S O Hietala; R Stenling; E Lundgren; Börje Ljungberg
Metastatic renal cell carcinoma treated with purified leukocyte interferon. Clinical response in relation to tumor DNA content.
Acta oncologica (Stockholm, Sweden) 1991;30(6):713-7.
1990: Börje Ljungberg; G Holmberg; J G Sjödin; SO Hietala; R Stenling
Renal cell carcinoma in a renal cyst: a case report and review of the literature.
The Journal of urology 1990;143(4):797-9.
1990: Börje Ljungberg; G Roos
Value of DNA analysis for treatment of renal cell carcinoma.
European urology 1990;18 Suppl 2():31-2.
1990: Göran Roos; Börje Ljungberg
DNA content in renal cell carcinoma and its clinical significance.
European urology 1990;18 Suppl 2():29-30.
1989: Börje Ljungberg; R Tomić; G Roos
Deoxyribonucleic acid content and medroxyprogesterone acetate treatment in metastatic renal cell carcinoma.
The Journal of urology 1989;141(6):1308-10.
1989: T K Nilsson; Radisa Tomic; Börje Ljungberg
Effects of high dose medroxyprogesterone acetate treatment on antithrombin III and other plasma proteins in males with renal cell or prostatic carcinoma.
Scandinavian journal of urology and nephrology 1989;23(1):11-4.
1988: Börje Ljungberg; R Stenling; G Roos
Tumor spread and DNA content in human renal cell carcinoma.
Cancer research 1988;48(11):3165-7.
1988: Börje Ljungberg; M Duchek; SO Hietala; G Roos; R Stenling
Renal cell carcinoma in a solitary kidney: late nephrectomy after 35 years and analysis of tumor deoxyribonucleic acid content.
The Journal of urology 1988;139(2):350-2.
1988: Börje Ljungberg; G Roos; R Stenling
Deoxyribonucleic acid content in metastatic renal cell carcinoma: clinical implications.
Seminars in surgical oncology 1988;4(3):165-8.
1988: G Holmberg; SO Hietala; Börje Ljungberg
A comparison of radiologic methods in the diagnosis of renal mass lesions.
Scandinavian journal of urology and nephrology 1988;22(3):187-96.
1988: Radisa Tomic; Börje Ljungberg; Jan-Erik Damber
Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
Scandinavian journal of urology and nephrology. Supplementum 1988;110():185-7.
1988: R Tomić; Börje Ljungberg; Jan-Erik Damber
Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
Scandinavian journal of urology and nephrology 1988;22(1):15-8.
1987: Börje Ljungberg; Roger Stenling; Göran Roos
Flow cytometric DNA analysis of renal-cell carcinoma. A study of fine needle aspiration biopsies in comparison with multiple surgical samples.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1987;9(6):505-8.